These results indicate a significant association between lower all-cause mortality risk in patients with metabolic syndrome and higher log2-transformed serum klotho levels in the Q2, Q3, and Q4 groups compared to the Q1 group. The gene discussed is KL; the disease is metabolic syndrome.